Guest: James Lewis II, PharmD, FIDSA Guest: George Thompson III, MD, FIDSA Have you ever wondered what went wrong in the management of invasive fungal infections? Through a storytelling approach Dr. James Lewis & Dr. George Thompson discuss a c

Host: Richard T. Penson, MD, MRCP Guest: Ana Oaknin, MD Therapeutic choices for many women with advanced endometrial cancer are being driven by our understanding of the mismatch repair (deficient/proficient) and microsatellite (instable/stable) sta

Host: Hector O. Chapa, MD Guest: Colin Quinn, MD Guest: Matthew Wicklund, MD Dr. Colin Quinn and Dr. Matthew Wicklund discuss the genetic and pathophysiologic underpinnings of limb girdle muscular dystrophy, as well as the use of appropriate diag

Host: Richard T. Penson, MD, MRCP Guest: Nicoletta Colombo, MD Guest: Christine Ghione Therapeutic options are changing for many patients with advanced endometrial cancer. Join us as Dr. Richard Penson and Dr. Nicoletta Colombo discuss new immuno

Host: Matthew R. Weir, MD Guest: Gates B. Colbert, MD Guest: Robert Toto, MD Hyperkalemia (HK) is a major impediment to optimizing RAASi therapy in various patient populations. Fortunately, newer treatments are now available to mitigate this adve

Host: Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Guest: Joseph Lim, MD Guest: Danny Chu, MD Guest: Jian Q. Zhang, DNP, MS, FNP-BC, NEA-BC, FAAN Experts in chronic hepatitis B within Asian communities discuss prevention, screening and management op

Guest: Kevan C. Herold, MD Guest: Chantal Mathieu, MD, PhD Experts in the immunopathology of type 1 diabetes discuss the epidemiology, non-genetic and genetic risk factors, and progression from preclinical to clinical stages of this disease. The di

Host: Jennifer Caudle, DO Guest: Crystal Proud, MD Guest: Edward Clinton Smith, MD Dr. Crystal Proud and Dr. Edward Smith discuss the relationship of DMD genetics and pathophysiology and explain the importance of early diagnosis of Duchenne Muscu

Guest: David Eichenbaum, MD Guest: Charles Wykoff, MD, PhD Current challenges in the treatment of neovascular retinal disease include the tremendous burden of treatment and suboptimal response to treatment in many cases. Strides have been made rece

Host: Robert Mocharnuk, MD Guest: Johan de Bono, MB, ChB FRCP, MSc, PhD, FMedSci Guest: Neeraj Agarwal, MD During recent years, advances in the understanding of the underlying genetic events and biology in prostate cancer development, including t